Publicaciones en las que colabora con Maria Angeles Muñoz Fernandez (17)

2013

  1. Association of torque teno virus (TTV) and torque teno mini virus (TTMV) with liver disease among patients coinfected with human immunodeficiency virus and hepatitis C virus

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 32, Núm. 2, pp. 289-297

2012

  1. Plasma IL-6 and IL-9 predict the failure of interferon-α plus ribavirin therapy in HIV/HCV-coinfected patients

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 5, pp. 1238-1245

2011

  1. Adipokine profiles and lipodystrophy in HIV-infected children during the first 4 years on highly active antiretroviral therapy

    HIV Medicine, Vol. 12, Núm. 1, pp. 54-60

  2. Cardiovascular risk markers are increased in HIV-infected children with lipodystrophy syndrome

    Journal of Infection

  3. High plasma fractalkine (CX3CL1) levels are associated with severe liver disease in HIV/HCV co-infected patients with HCV genotype 1

    Cytokine, Vol. 54, Núm. 3, pp. 244-248

  4. Sustained virological response to interferon-α plus ribavirin decreases inflammation and endothelial dysfunction markers in HIV/HCV co-infected patients

    Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 3, pp. 645-649

2010

  1. Association between lipodystrophy and leptin in human immunodeficiency virus-1-infected children receiving lopinavir/ritonavir-based therapy

    Pediatric Infectious Disease Journal, Vol. 29, Núm. 8, pp. 774-777

  2. Diagnosis of advanced fibrosis in HIV and hepatitis C virus-coinfected patients via a new noninvasive index: The HGM-3 index

    HIV Medicine, Vol. 11, Núm. 1, pp. 64-73

  3. Hepatitis C virus infection is associated with endothelial dysfunction in HIV/hepatitis C virus coinfected patients

    AIDS, Vol. 24, Núm. 13, pp. 2059-2067

2009

  1. Can serum hyaluronic acid replace simple non-invasive indexes to predict liver fibrosis in HIV/Hepatitis C coinfected patients?

    BMC Infectious Diseases, Vol. 10

  2. Serum levels of fibrosis biomarkers measured early after liver transplantation are associated with severe hepatitis C virus recurrence: Short communication

    Transplant Infectious Disease, Vol. 11, Núm. 2, pp. 183-188

2008

  1. Immunological recovery and metabolic disorders in severe immunodeficiency HIV type 1-infected children on highly active antiretroviral therapy

    AIDS Research and Human Retroviruses, Vol. 24, Núm. 12, pp. 1477-1484

  2. Lipid and apoprotein profile in HIV-1-infected patients after CD4-guided treatment interruption

    Journal of Acquired Immune Deficiency Syndromes, Vol. 48, Núm. 4, pp. 455-459

  3. Negative influence of age on CD4+ cell recovery after highly active antiretroviral therapy in naïve HIV-1-infected patients with severe immunodeficiency

    Journal of Infection, Vol. 56, Núm. 2, pp. 130-136

2007

  1. Long-term response to highly active antiretroviral therapy in human immunodeficiency virus and hepatitis C virus coinfected children: 6 Years of follow-up

    Pediatric Infectious Disease Journal, Vol. 26, Núm. 11, pp. 1061-1064

  2. Slow progression of human immunodeficiency virus and hepatitis C virus disease in a cohort of coinfected children

    Pediatric Infectious Disease Journal, Vol. 26, Núm. 9, pp. 846-849

2006

  1. Clinical outcomes improve with highly active antiretroviral therapy in vertically HIV type-1-infected children

    Clinical Infectious Diseases, Vol. 43, Núm. 2, pp. 243-252